JS

Jay Shyamkumar Hande

Active Director Director DIN 10586363
DIN 10586363 First appointment Apr 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Jay Shyamkumar Hande

Data last updated:

Jay Shyamkumar Hande is a Director at Silitzer Pharma Private Limited (since 2024). The company operates in Healthcare.

DIN 10586363
Primary Designation Director
Industry Healthcare
First Appointment 10 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Silitzer Pharma Private Limited U46596PN2024PTC230019
Director10 Apr 20242024Active

Board colleagues of Jay Shyamkumar Hande

Directorship timeline

Open interactive timeline →
Silitzer Pharma Private Limited
Premium access

Shareholding and investment profile for Jay Shyamkumar Hande

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jay Shyamkumar Hande

Jay Shyamkumar Hande currently holds 1 directorship: Silitzer Pharma Private Limited (Director, since 10 Apr 2024).

Jay Shyamkumar Hande was first appointed on 10 Apr 2024 as Director at Silitzer Pharma Private Limited.

The current boards of Jay Shyamkumar Hande's companies include Bharadwaj Ravindra Bedkihal (Silitzer Pharma Private Limited), Pankaj Prabhakar Mahabaleshwarkar (Silitzer Pharma Private Limited), Yash Rajkumar Parsewar (Silitzer Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available